Albany Molecular Research Inc (AMRI)

18.81
NASDAQ : Health Care
Prev Close 18.40
Day Low/High 17.94 / 18.98
52 Wk Low/High 12.51 / 19.35
Avg Volume 772.50K
Exchange NASDAQ
Shares Outstanding 42.93M
Market Cap 789.94M
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week of June 16th Options Trading For Albany Molecular Research (AMRI)

Investors in Albany Molecular Research Inc saw new options begin trading this week, for the June 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRI options chain for the new June 16th contracts and identified one put and one call contract of particular interest.

Denovo Biopharma Obtains Exclusive License To Liafensine From AMRI

- Denovo Biopharma gains an exclusive license to all rights to develop, manufacture and commercialize liafensine globally

First Week Of May 19th Options Trading For Albany Molecular Research (AMRI)

Investors in Albany Molecular Research Inc saw new options become available this week, for the May 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRI options chain for the new May 19th contracts and identified one put and one call contract of particular interest.

Albany Molecular Research Becomes Oversold (AMRI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Albany Molecular Research

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting AMRI Put And Call Options For February 17th

Interesting AMRI Put And Call Options For February 17th

Investors in Albany Molecular Research Inc saw new options become available this week, for the February 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRI options chain for the new February 17th contracts and identified one put and one call contract of particular interest.

Short Interest Jumps 12.7% For AMRI

Short Interest Jumps 12.7% For AMRI

The most recent short interest data has been released for the 12/15/2016 settlement date, which shows a 659,489 share increase in total short interest for Albany Molecular Research Inc , to 5,850,245, an increase of 12.71% since 11/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Albany Molecular Research Becomes Oversold (AMRI)

Albany Molecular Research Becomes Oversold (AMRI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

AMRI: Insiders vs. Shorts

AMRI: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/29/2016 settlement date, and Albany Molecular Research Inc is one of the most shorted stocks of the Russell 3000, based on 17.15 "days to cover" versus the median component at 6.42. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.